On February 10, 2023, the Company committed $100,000 to purchase an equity membership interest in a federal low-income housing tax credit entity. An initial payment of $20,000 was paid at closing with the remaining balance payable in quarterly installments over a five-year period beginning in fiscal 2024. The present value of such payments was $62,120 and was recorded as an increase to the initial tax credit investment asset and liability. In exchange for the total payments of $100,000, the Company expects to realize a comparable amount of tax credits and other tax benefits that will reduce its future federal income tax payments. Although the investment vehicle is considered a variable interest entity, the Company is not the primary beneficiary, and therefore, the investment is not consolidated. The Company has elected to use the practical expedient method of amortization, which approximates the proportional amortization method, to amortize the investment to income tax expense in proportion to the tax credits received over an estimated 10-year tax credit period beginning in the first quarter of fiscal 2024. The Company included in "Other income, net" in the Condensed Consolidated Statements of Income, interest expense related to the accretion of the liability of $1,221 and $3,763 for the three and nine months ended October 31, 2024, respectively, and $1,344 and $4,875 for the three and nine months ended October 31, 2023, respectively. Included in "Income tax expense" in the Condensed Consolidated Statements of Income was amortization of the investment of $4,112 and $12,872 for the three and nine months ended October 31, 2024, respectively, and $3,976 and $11,929 for the three and nine months ended October 31, 2023, respectively. Also included in "Income tax expense" in the Condensed Consolidated Statements of Income were income tax credits and other income tax benefits of $6,012 and $18,262 for the three and nine months ended October 31, 2024, respectively, and $5,600 and $16,979 for the three and nine months ended October 31, 2023, respectively. The carrying value of the investment is recorded in "Other assets" in the Condensed Consolidated Balance Sheets. The liabilities for the present value of the estimated future capital contributions are recorded in "Accrued expenses, accrued compensation and other current liabilities" and "Other non-current liabilities" in the Condensed Consolidated Balance Sheets. The following table summarizes the balances related to the investment at October 31, 2024, January 31, 2024 and October 31, 2023:


	October 31,		January 31,		October 31,
	2024		2024		2023
Other assets	$	53,136	$	66,214	$	70,190
Accrued expenses, accrued compensation and other current liabilities		16,878		10,507		7,738
Other non-current liabilities		34,497		47,293		51,375